Roche Chairman: Antibiotics must not be seen as a mass market product
A shift in the way governments and healthcare systems view antibiotics is needed if the impact of antimicrobial resistance (AMR) is to be curbed in the coming years, according to Severin Schwan, Chairman and former CEO of Roche.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.